Q32 Bio Inc. business relationships
Companies named in Q32 Bio Inc.’s 10-K filed 2026-03-10, and public companies whose annual reports name Q32 Bio Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.6 / 10
- AI naming
- 2 / 100 Top 9% in its category
- Agent readiness
- 5 / 100
- AI adoption
- 0 / 100
Named in Q32 Bio Inc.’s annual report 2
“Bempikibart-License Agreement - Bristol-Myers Squibb Company” SEC filing
“During the year ended December 31, 2025, we had net income of $29.8 million as a result of the collaboration revenue recognized upon the execution of the Amgen Amendment.” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.